Fc Receptors As Adaptive Immunoreceptors
Overview
Microbiology
Authors
Affiliations
Most biological activities of antibodies depend on their ability to engage Receptors for the Fc portion of immunoglobulins (FcRs) on a variety of cell types. As FcRs can trigger positive and negative signals, as these signals control several biological activities in individual cells, as FcRs are expressed by many cells of hematopoietic origin, mostly of the myeloid lineage, as these cells express various combinations of FcRs, and as FcR-expressing cells have different functional repertoires, antibodies can exert a wide spectrum of biological activities. Like B and T Cell Receptors (BCRs and TCRs), FcRs are bona fide immunoreceptors. Unlike BCRs and TCRs, however, FcRs are immunoreceptors with an adaptive specificity for antigen, with an adaptive affinity for antibodies, with an adaptive structure and with an adaptive signaling. They induce adaptive biological responses that depend on their tissue distribution and on FcR-expressing cells that are selected locally by antibodies. They critically determine health and disease. They are thus exquisitely adaptive therapeutic tools.
Immunomodulatory and anti-inflammatory properties of immunoglobulin G antibodies.
Hematianlarki M, Nimmerjahn F Immunol Rev. 2024; 328(1):372-386.
PMID: 39340138 PMC: 11659946. DOI: 10.1111/imr.13404.
Wang J, Wu J, Ma Y, Hao L, Huang W, Liu Z Fish Physiol Biochem. 2024; 50(3):1123-1140.
PMID: 38407736 DOI: 10.1007/s10695-024-01325-6.
Insulin-regulated aminopeptidase contributes to setting the intensity of FcR-mediated inflammation.
Bratti M, Vibhushan S, Longe C, Koumantou D, Menasche G, Benhamou M Front Immunol. 2022; 13:1029759.
PMID: 36389775 PMC: 9647545. DOI: 10.3389/fimmu.2022.1029759.
The immune system as a system of relations.
Daeron M Front Immunol. 2022; 13:984678.
PMID: 36177051 PMC: 9513551. DOI: 10.3389/fimmu.2022.984678.
Avidity in antibody effector functions and biotherapeutic drug design.
Oostindie S, Lazar G, Schuurman J, Parren P Nat Rev Drug Discov. 2022; 21(10):715-735.
PMID: 35790857 PMC: 9255845. DOI: 10.1038/s41573-022-00501-8.